Home / Business and Economy / Hospital Sues Pharma Giant Over Drug Discounts
Hospital Sues Pharma Giant Over Drug Discounts
10 Jul
Summary
- Tampa General Hospital sues Eli Lilly over drug pricing changes.
- Eli Lilly stopped discounted medications to safety-net hospitals.
- Patient faces $5,000 monthly cost for a previously $5 medication.
Tampa General Hospital initiated legal action against Eli Lilly and Company last week, alleging illegal profit-taking. This lawsuit stems from Eli Lilly's termination of discounted drug supplies, previously provided under a federal initiative supporting safety-net hospitals serving low-income patients.
The hospital reports that the withdrawal of price reductions caused its spending on Lilly products to surge by 25%-50%. This change has directly affected patients; an 80-year-old patient's monthly osteoporosis medication cost increased from approximately $5 to an estimated $5,000.
Eli Lilly defended its actions, stating the lawsuit represents a hospital effort to obscure fraud, waste, and abuse. The company claims that requiring hospitals to share claims data, information already submitted to insurers, is necessary to improve program integrity.
For over 30 years, the 340B program has facilitated drug discounts for safety-net hospitals. However, Eli Lilly announced in January it would mandate claims-data submission from participating entities, a move attorneys for Tampa General argue exceeds the company's authority and violates Florida law.
Attorneys representing the hospital contend that Eli Lilly is unfairly tarnishing all program participants by broadly alleging fraud without specific evidence. They emphasize that federal agencies are responsible for monitoring the program, not for-profit companies unilaterally imposing new conditions and demanding sensitive data.
